Jin-Hee Ahn
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid Tumor (NCT04215159) | Jin-Hee Ahn | 2019-12-30 |
Track Jin-Hee Ahn automatically
Every clearance here is in the API, with alerts when new ones post.